Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
Clinical trial NCT04688632 · COMPLETED
Trial details
- NCT number
- NCT04688632
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-18
- Primary completion
- 2021-03-13
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.